RSLS - ReShape Lifesciences Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

ReShape Lifesciences Inc.

1001 Calle Amanecer
San Clemente, CA 92673
United States
949-429-6680
http://www.reshapelifesciences.com

SectorHealthcare
IndustryMedical Devices
Full Time Employees83

Key Executives

NameTitlePayExercisedYear Born
Mr. Dan W. GladneyChairman, Pres & CEO463.72kN/A1953
Mr. Scott P. YoungstromCFO, Sr. VP of Fin. & Sec.65.42kN/A1960
Mr. Naqeeb A. AnsariVP of Worldwide Sales298.33kN/A1961
Dr. Mark B. Knudson Ph.D.Co-Founder and Special Advisor to the CEON/AN/A1949
Dr. Katherine S. Tweden Ph.D.Co-FounderN/AN/A1961
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ReShape Lifesciences Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology, vBloc Therapy is designed to intermittently block the vagus nerve using electrical impulses. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; and ReShape Balloon system that uses balloon technology designed to take up room in the stomach to enable people lose weight. Its product portfolio also comprises ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.

Corporate Governance

ReShape Lifesciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.